Journal
JOURNAL OF HUMAN GENETICS
Volume 52, Issue 1, Pages 1-12Publisher
NATURE PUBLISHING GROUP
DOI: 10.1007/s10038-006-0078-1
Keywords
Marfan syndrome; FBN1; TGFBR1; TGFBR2; TGF beta signaling; genetic heterogeneity; Loeys-Dietz syndrome; familial thoracic aortic aneurysms and dissections
Categories
Ask authors/readers for more resources
Marfan syndrome (MFS, OMIM #154700) is a hereditary connective tissue disorder, clinically presenting with cardinal features of skeletal, ocular, and cardiovascular systems. In classical MFS, changes in connective tissue integrity can be explained by defects in fibrillin-1, a major component of extracellular microfibrils. However, some of the clinical manifestations of MFS cannot be explained by mechanical properties alone. Recent studies manipulating mouse Fbn1 have provided new insights into the molecular pathogenesis of MFS. Dysregulation of transforming growth factor beta (TGF beta) signaling in lung, mitral valve and aortic tissues has been implicated in mouse models of MFS. TGFBR2 and TGFBR1 mutations were identified in a subset of patients with MFS (MFS2, OMIM #154705) and other MFS-related disorders, including Loeys-Dietz syndrome (LDS, #OMIM 609192) and familial thoracic aortic aneurysms and dissections (TAAD2, #OMIM 608987). These data indicate that genetic heterogeneity exists in MFS and its related conditions and that regulation of TGF beta signaling plays a significant role in these disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available